Lung cancer risk from CT scans in people with a family history
Official title: LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B
Run by Massachusetts General Hospital · NCT07600801 · Data updated 2026-11-12
Researchers test a deep learning model called Sybil to see if chest CT images can predict future lung cancer risk in people who have relatives with the disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2250 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | June 17, 2026 |
| Main results expected | December 31, 2033 |
| Study ends | December 31, 2035 |
| Registry record updated | August 25, 2026 |
| Trial ID | NCT07600801 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with at least one first-degree or two second-degree relatives diagnosed with lung cancer who can provide at least one prior chest CT image.
✕Probably not a fit
Individuals without available prior CT images or without a qualifying family history may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study enrolling adults with a family history of lung cancer. Participants provide a questionnaire about medical history and exposures and share chest CT images from previous scans. The study uses an image-based AI model (Sybil) to estimate each person’s future risk of developing lung cancer based on those CT images. The goal is to determine how well Sybil predicts risk in this specific, higher-risk population. About 2,250 participants are planned to enroll at Massachusetts General Hospital.
Why it matters
Potential benefit: If successful, the approach could help identify high-risk individuals for closer monitoring or early detection strategies.
How similar studies have gone: Previous work with similar imaging-based AI approaches has shown promise in risk prediction, but applicability to people with a family history has not been fully established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18 years of age * Positive family history of lung cancer (defined as): * Has ≥1 first-degree relative OR * Has ≥2 second-degree relatives with a diagnosis of non-small cell lung cancer or small cell lung cancer (NB: a first-degree relative = parent, sibling, or child, a second-degree relative = grandparent, blood-related aunt or uncle, grandchild, blood-related niece or nephew, half-sibling) * Willing to provide images from at least one previously obtained CT Chest scan, if available. Exclusion Criteria: \- None
Where it's running
-
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Allison Chang, MD — Massachusetts General Hospital
- Study coordinator: Allison Chang, MD
- Email: aechang@mgb.org
- Phone: 617-724-4000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reach and Engagement of Genetic Education, Risk Assessment, and Testing Feasibility (GENET) for PDAC risk
This study tests whether online education plus a phone call from PanCAN helps Black, Latino/a, and Medicaid-enrolled people in Massachusetts learn about genetic and multi-cancer early detection testing and decide about getting tested.
-
Registry for patients with pancreatic diseases
This study is creating a registry to collect information from patients with pancreatic diseases to help researchers understand what causes these conditions and how to prevent them.
-
Non-endoscopic test to find Barrett's esophagus in veterans without chronic reflux.
This project will test whether a simple, non-endoscopic swab-like test can find Barrett's esophagus in veterans over 40 who have risk factors for esophageal cancer but no chronic heartburn.
-
Imaging cannabinoid receptors in the brain using PET scans
This study is trying to see how many cannabinoid receptors are in the brains of healthy people and those with conditions like cannabis use disorders or PTSD using special brain scans.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.